دورية أكاديمية
Monogenic obesity; using drugs to bypass the problem
العنوان: | Monogenic obesity; using drugs to bypass the problem |
---|---|
المؤلفون: | Coll, anthony |
بيانات النشر: | Elsevier //dx.doi.org/10.1016/j.cmet.2018.06.015 Cell Metabolism |
سنة النشر: | 2018 |
المجموعة: | Apollo - University of Cambridge Repository |
مصطلحات موضوعية: | Body Weight, Glucagon-Like Peptide-1 Receptor, Humans, Mutation, Obesity, Receptor, Melanocortin, Type 4 |
الوصف: | Safe and effective pharmacological treatments for severe obesity remain scarce. In this issue, Iepsen et al. show that obese patients with pathogenic melanocortin 4 receptor mutations, the most common form of monogenic obesity, lose weight with glucagon-like peptide 1 (GLP-1) receptor agonist therapy. ; A.P.C. is supported by the Medical Research Council (MRC Metabolic Diseases Unit [MRC_MC_UU_12012/1]). |
نوع الوثيقة: | article in journal/newspaper |
وصف الملف: | application/pdf |
اللغة: | English |
العلاقة: | https://www.repository.cam.ac.uk/handle/1810/283544Test |
DOI: | 10.17863/CAM.30907 |
الإتاحة: | https://doi.org/10.17863/CAM.30907Test https://www.repository.cam.ac.uk/handle/1810/283544Test |
حقوق: | Attribution-NonCommercial-NoDerivatives 4.0 International |
رقم الانضمام: | edsbas.576A4D15 |
قاعدة البيانات: | BASE |
DOI: | 10.17863/CAM.30907 |
---|